These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20570896)

  • 1. Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer.
    Lin RK; Wu CY; Chang JW; Juan LJ; Hsu HS; Chen CY; Lu YY; Tang YA; Yang YC; Yang PC; Wang YC
    Cancer Res; 2010 Jul; 70(14):5807-17. PubMed ID: 20570896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
    Estève PO; Chin HG; Pradhan S
    J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNMT3B overexpression by deregulation of FOXO3a-mediated transcription repression and MDM2 overexpression in lung cancer.
    Yang YC; Tang YA; Shieh JM; Lin RK; Hsu HS; Wang YC
    J Thorac Oncol; 2014 Sep; 9(9):1305-15. PubMed ID: 25122426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer.
    Tang YA; Lin RK; Tsai YT; Hsu HS; Yang YC; Chen CY; Wang YC
    Clin Cancer Res; 2012 Aug; 18(16):4325-33. PubMed ID: 22733537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53.
    Lai JC; Cheng YW; Goan YG; Chang JT; Wu TC; Chen CY; Lee H
    DNA Repair (Amst); 2008 Aug; 7(8):1352-63. PubMed ID: 18555750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
    Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
    Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer.
    Wu DW; Liu WS; Wang J; Chen CY; Cheng YW; Lee H
    Clin Cancer Res; 2011 Apr; 17(7):1895-905. PubMed ID: 21325288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 negatively regulates the human telomerase RNA gene promoter.
    Zhao J; Bilsland A; Jackson K; Keith WN
    BMC Cancer; 2005 Jan; 5():6. PubMed ID: 15656906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells.
    Guo D; Wu B; Yan J; Li X; Sun H; Zhou D
    Biochem Biophys Res Commun; 2012 Nov; 428(1):80-5. PubMed ID: 23047008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous sphingosine-1-phosphate lyase gene expression and its regulatory mechanism in human lung cancer cell lines.
    Ito H; Yoshida K; Murakami M; Hagiwara K; Sasaki N; Kobayashi M; Takagi A; Kojima T; Sobue S; Suzuki M; Tamiya-Koizumi K; Nakamura M; Banno Y; Nozawa Y; Murate T
    Biochim Biophys Acta; 2011 Mar; 1811(3):119-28. PubMed ID: 21184844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
    Pietrzak M; Puzianowska-Kuznicka M
    Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor.
    Bocangel D; Sengupta S; Mitra S; Bhakat KK
    Anticancer Res; 2009 Oct; 29(10):3741-50. PubMed ID: 19846904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB.
    Króliczak W; Pietrzak M; Puzianowska-Kuznicka M
    Acta Biochim Pol; 2008; 55(3):559-70. PubMed ID: 18714402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding.
    Peterson EJ; Bögler O; Taylor SM
    Cancer Res; 2003 Oct; 63(20):6579-82. PubMed ID: 14583449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters.
    Estève PO; Chin HG; Pradhan S
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1000-5. PubMed ID: 15657147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal medicine Xiaoji decoction inhibited growth of lung cancer cells through AMPKα-mediated inhibition of Sp1 and DNA methyltransferase 1.
    Zhao S; Wu J; Tang Q; Zheng F; Yang L; Chen Y; Li L; Hann SS
    J Ethnopharmacol; 2016 Apr; 181():172-81. PubMed ID: 26850724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP).
    Cuesta A; Zambrano A; Royo M; Pascual A
    Biochem J; 2009 Mar; 418(3):643-50. PubMed ID: 19049493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein Represses Cellular MDM2 Expression via Suppressing the Sp1- and p53-Mediated Transactivation.
    Lin CI; Wang SS; Hung CH; Chang PJ; Chen LW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells.
    Wu J; Zhao S; Tang Q; Zheng F; Chen Y; Yang L; Yang X; Li L; Wu W; Hann SS
    J Exp Clin Cancer Res; 2015 Sep; 34(1):99. PubMed ID: 26362062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.